The Monocytic Cell Line THP-1 As a Validated and Robust Surrogate Model for Human Dendritic Cells

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Jan 21

PMID 36674966

Authors

Johanna Maria Holken

Nicole Teusch

Affiliations

Soon will be listed here.

Abstract

We have implemented an improved, cost-effective, and highly reproducible protocol for a simple and rapid differentiation of the human leukemia monocytic cell line THP-1 into surrogates for immature dendritic cells (iDCs) or mature dendritic cells (mDCs). The successful differentiation of THP-1 cells into iDCs was determined by high numbers of cells expressing the DC activation markers CD54 (88%) and CD86 (61%), and the absence of the maturation marker CD83. The THP-1-derived mDCs are characterized by high numbers of cells expressing CD54 (99%), CD86 (73%), and the phagocytosis marker CD11b (49%) and, in contrast to THP-1-derived iDCs, CD83 (35%) and the migration marker CXCR4 (70%). Treatment of iDCs with sensitizers, such as NiSO and DNCB, led to high expression of CD54 (97%/98%; GMFI, 3.0/3.2-fold induction) and CD86 (64%/96%; GMFI, 4.3/3.2-fold induction) compared to undifferentiated sensitizer-treated THP-1 (CD54, 98%/98%; CD86, 55%/96%). Thus, our iDCs are highly suitable for toxicological studies identifying potential sensitizing or inflammatory compounds. Furthermore, the expression of CD11b, CD83, and CXCR4 on our iDC and mDC surrogates could allow studies investigating the molecular mechanisms of dendritic cell maturation, phagocytosis, migration, and their use as therapeutic targets in various disorders, such as sensitization, inflammation, and cancer.

Citing Articles

Responses of an Coculture Alveolar Model for the Prediction of Respiratory Sensitizers (ALIsens) Following Exposure to Skin Sensitizers and Non-Sensitizers.

Burla S, Chary A, Serchi T, Cambier S, Sullivan K, Baker E Toxics. 2025; 13(1).

PMID: 39853027 PMC: 11769448. DOI: 10.3390/toxics13010029.

Innate Immune Response Against Batai Virus, Bunyamwera Virus, and Their Reassortants.

Zoller D, Saurich J, Metzger J, Jung K, Lepenies B, Becker S Viruses. 2025; 16(12.

PMID: 39772143 PMC: 11680289. DOI: 10.3390/v16121833.

Incorporating immune cell surrogates into a full-thickness tissue equivalent of human skin to characterize dendritic cell activation.

Holken J, Wurz A, Friedrich K, Bottcher P, Asskali D, Stark H Sci Rep. 2024; 14(1):30158.

PMID: 39627401 PMC: 11615323. DOI: 10.1038/s41598-024-81014-9.

Distinct transcriptome and traits of freshly dispersed cells.

Kalia M, Sauer K mSphere. 2024; 9(12):e0088424.

PMID: 39601567 PMC: 11656770. DOI: 10.1128/msphere.00884-24.

The Toxoplasma secreted effector TgWIP modulates dendritic cell motility by activating host tyrosine phosphatases Shp1 and Shp2.

Morales P, Brown A, Sangare L, Yang S, Kuihon S, Chen B Res Sq. 2024; .

PMID: 38978596 PMC: 11230507. DOI: 10.21203/rs.3.rs-4539584/v1.

References

Tait Wojno E, Hunter C, Stumhofer J . The Immunobiology of the Interleukin-12 Family: Room for Discovery. Immunity. 2019; 50(4):851-870. PMC: 6472917. DOI: 10.1016/j.immuni.2019.03.011. View

Lim T, Goh J, Mortellaro A, Lim C, Hammerling G, Ricciardi-Castagnoli P . CD80 and CD86 differentially regulate mechanical interactions of T-cells with antigen-presenting dendritic cells and B-cells. PLoS One. 2012; 7(9):e45185. PMC: 3443229. DOI: 10.1371/journal.pone.0045185. View

Braun A, Worbs T, Moschovakis G, Halle S, Hoffmann K, Bolter J . Afferent lymph-derived T cells and DCs use different chemokine receptor CCR7-dependent routes for entry into the lymph node and intranodal migration. Nat Immunol. 2011; 12(9):879-87. DOI: 10.1038/ni.2085. View

Kiertscher S, Roth M . Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4. J Leukoc Biol. 1996; 59(2):208-18. DOI: 10.1002/jlb.59.2.208. View

Ceradini D, Kulkarni A, Callaghan M, Tepper O, Bastidas N, Kleinman M . Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004; 10(8):858-64. DOI: 10.1038/nm1075. View

Aiba S, Manome H, Nakagawa S, Mollah Z, Mizuashi M, Ohtani T . p38 Mitogen-activated protein kinase and extracellular signal-regulated kinases play distinct roles in the activation of dendritic cells by two representative haptens, NiCl2 and 2,4-dinitrochlorobenzene. J Invest Dermatol. 2003; 120(3):390-9. DOI: 10.1046/j.1523-1747.2003.12065.x. View

Sandor N, Kristof K, Parej K, Pap D, Erdei A, Bajtay Z . CR3 is the dominant phagocytotic complement receptor on human dendritic cells. Immunobiology. 2012; 218(4):652-63. DOI: 10.1016/j.imbio.2012.07.031. View

Kim C, Kim K, Lee H . The role of dendritic cells in tumor microenvironments and their uses as therapeutic targets. BMB Rep. 2020; 54(1):31-43. PMC: 7851442. View

Pasparakis M, Haase I, Nestle F . Mechanisms regulating skin immunity and inflammation. Nat Rev Immunol. 2014; 14(5):289-301. DOI: 10.1038/nri3646. View

10.

Hardonniere K, Szely N, El Ali Z, Pallardy M, Kerdine-Romer S . Models of Dendritic Cells to Assess Skin Sensitization. Front Toxicol. 2022; 4:851017. PMC: 8971372. DOI: 10.3389/ftox.2022.851017. View

11.

Li Z, Ju X, Silveira P, Abadir E, Hsu W, Hart D . CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential. Front Immunol. 2019; 10:1312. PMC: 6568190. DOI: 10.3389/fimmu.2019.01312. View

12.

Lanzavecchia A, Sallusto F . Regulation of T cell immunity by dendritic cells. Cell. 2001; 106(3):263-6. DOI: 10.1016/s0092-8674(01)00455-x. View

13.

Doebbeler M, Koenig C, Krzyzak L, Seitz C, Wild A, Ulas T . CD83 expression is essential for Treg cell differentiation and stability. JCI Insight. 2018; 3(11). PMC: 6124443. DOI: 10.1172/jci.insight.99712. View

14.

Toebak M, Gibbs S, Bruynzeel D, Scheper R, Rustemeyer T . Dendritic cells: biology of the skin. Contact Dermatitis. 2009; 60(1):2-20. DOI: 10.1111/j.1600-0536.2008.01443.x. View

15.

Scheurlen K, Snook D, Gardner S, Eichenberger M, Galandiuk S . Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line. J Vis Exp. 2021; (174). DOI: 10.3791/62652. View

16.

Ogasawara N, Kojima T, Go M, Fuchimoto J, Kamekura R, Koizumi J . Induction of JAM-A during differentiation of human THP-1 dendritic cells. Biochem Biophys Res Commun. 2009; 389(3):543-9. DOI: 10.1016/j.bbrc.2009.09.024. View

17.

Enk A, Jonuleit H, Saloga J, Knop J . Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int J Cancer. 1997; 73(3):309-16. DOI: 10.1002/(sici)1097-0215(19971104)73:3<309::aid-ijc1>3.0.co;2-3. View

18.

Joffre O, Segura E, Savina A, Amigorena S . Cross-presentation by dendritic cells. Nat Rev Immunol. 2012; 12(8):557-69. DOI: 10.1038/nri3254. View

19.

Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, Wolf E . CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell. 1999; 99(1):23-33. DOI: 10.1016/s0092-8674(00)80059-8. View

20.

Lechmann M, Berchtold S, Hauber J, Steinkasserer A . CD83 on dendritic cells: more than just a marker for maturation. Trends Immunol. 2002; 23(6):273-5. DOI: 10.1016/s1471-4906(02)02214-7. View